ArticleJournal of hepatology2022
Focus on the decisions to forego life-sustaining therapies during ICU stay of patients with cirrhosis and COVID-19: A case control study from the prospective COVID-ICU database.
Mikhael Giabicani et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.